Form 8-K
0001423221 False 0001423221 2024-06-06 2024-06-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 6, 2024

_______________________________

Quanex Building Products Corporation

(Exact name of registrant as specified in its charter)

_______________________________

Delaware001-3391326-1561397
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

945 Bunker Hill Road, Suite 900

Houston, Texas 77024

(Address of Principal Executive Offices) (Zip Code)

(713) 961-4600

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareNXNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 2.02. Results of Operations and Financial Condition.

On June 6, 2024, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.
   
99.1 Press Release dated June 6, 2024
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Quanex Building Products Corporation
   
  
Date: June 6, 2024By: /s/ SCOTT ZUEHLKE        
  Scott Zuehlke
  SVP, CFO and Treasurer
  

 

EdgarFiling

EXHIBIT 99.1

Quanex Building Products Announces Second Quarter 2024 Results and Reaffirms Full Year 2024 Guidance

Margin Expansion in North America and on a Consolidated Basis
Repaid $10 Million in Bank Debt – No Outstanding Draws on Revolver
Tyman Acquisition Expected to Close in 2H24

HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2024.  

The Company reported the following selected financial results:

 Three Months Ended April 30, Six Months Ended April 30,
($ in millions, except per share data)2024 2023 2024 2023
Net Sales$266.2 $273.5 $505.4 $535.5
Gross Margin$66.2 $67.2 $117.7 $118.9
Gross Margin %24.9% 24.6% 23.3% 22.2%
Net Income$15.4 $21.5 $21.6 $23.4
Diluted EPS$0.46 $0.65 $0.65 $0.71
        
Adjusted Net Income$21.8 $21.7 $27.6 $27.8
Adjusted Diluted EPS$0.66 $0.66 $0.83 $0.84
Adjusted EBITDA$40.0 $39.9 $59.3 $60.4
Adjusted EBITDA Margin %15.0% 14.6% 11.7% 11.3%
        
Cash Provided by Operating Activities$33.1 $35.3 $36.9 $38.5
Free Cash Flow$25.5 $27.8 $19.8 $23.4

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Our second quarter results came in as expected and we continue to execute. Volumes in North America increased in the second quarter compared to the first quarter of the year, which is encouraging and follows normal seasonality in our business. Volumes in Europe were challenged during the quarter as low consumer confidence continues to impact demand. However, we continue to operate efficiently and were able to realize margin expansion in both of our North American operating segments and on a consolidated basis for the second quarter of 2024. Our continued focus on generating cash and managing working capital enabled us to pay down the remaining $10 million balance on our revolver.”

Second Quarter 2024 Results Summary

Quanex reported net sales of $266.2 million during the three months ended April 30, 2024, which represents a decrease of 2.7% compared to $273.5 million for the same period of 2023. The decrease was largely attributable to softer market demand in the Company’s European Fenestration and North American Cabinet Components segments. Quanex reported a 1.8% increase in net sales for the second quarter in its North American Fenestration segment primarily due to improved volume. In its North American Cabinet Components segment, the Company reported a decline of 4.6% in net sales for the second quarter as a result of lower volume and decreased pricing related to raw material index pricing mechanisms. Excluding foreign exchange impact, Quanex realized a decrease in net sales of 10.4% for the second quarter in its European Fenestration segment mainly due to lower volume and pricing pressure. (See Sales Analysis table for additional information)

The increase in adjusted earnings for the three months ended April 30, 2024 was mostly attributable to a decline in raw material costs, lower income tax expense and lower interest expense.

Balance Sheet Update

As of April 30, 2024, Quanex had total debt of $55.2 million (primarily finance leases) and the Company’s leverage ratio of Net Debt to LTM Adjusted EBITDA continued to improve and Quanex is Net Debt free. As of April 30, 2024, the Company’s LTM Net Income was $80.7 million and LTM Adjusted EBITDA was $158.5 million.   (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Outlook

Mr. Wilson stated, “As expected, we are starting to see a seasonal uptick in the demand for our products in North America. Market dynamics in Europe continue to be challenging and volumes are soft; however, we are performing well, and our business is resilient. Based on results to date, conversations with our customers, recent demand trends, and the latest macro data, we are reaffirming our prior guidance for fiscal 2024. On a consolidated basis, we continue to estimate net sales of approximately $1.1 billion, which should result in approximately $145 million to $150 million of Adjusted EBITDA* in fiscal 2024.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

Recent Events

As previously disclosed on April 22, 2024, Quanex announced it had reached agreement with Tyman plc (LSE:TYMN) (“Tyman”) on the terms of a recommended cash and share offer (the “Acquisition”), under which Quanex will acquire the entire issued and to be issued share capital of Tyman for approximately $1.1 billion in enterprise value. The full terms and conditions of the Acquisition are set out in a joint announcement released on April 22, 2024 under Rule 2.7 of the UK Takeover Code. A copy of this announcement is available on the Quanex website at https://www.roadto2b.com, subject to certain access restrictions. The Acquisition has been unanimously approved by the Boards of Directors of both Quanex and Tyman and is currently expected to close in the second half of the calendar year 2024, subject to the satisfaction of customary closing conditions, including shareholder approval from both Tyman and Quanex shareholders and regulatory approvals.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, June 7, 2024 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI8e90696b55d04353a1f5e63939f8a6f6

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration, custom mixing and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the Acquisition, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

Important Additional Information will be Filed with the SEC

In connection with the Acquisition, Quanex filed with the U.S. Securities and Exchange Commission (the “SEC”) a definitive proxy statement on June 6, 2024 (the “Proxy Statement”). Before making any voting decision, Quanex’s stockholders are urged to read the Proxy Statement and other relevant documents filed or to be filed with the SEC in connection with the Acquisition or incorporated by reference in the Proxy Statement carefully and in their entirety because they contain important information about the Acquisition and the share issuance proposal. Quanex’s stockholders and investors will be able to obtain, without charge, a copy of the Proxy Statement and other relevant documents filed with the SEC from the SEC’s website at http://www.sec.gov or directing a written request to Quanex (Attention: Investor Relations), at 945 Bunker Hill Road, Suite 900, Houston, Texas 77024 or from Quanex’s website at https://investors.quanex.com.

No Offer or Solicitation

The information contained in this press release is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. In particular, this press release is not an offer of securities for sale into the United States or in any other jurisdiction. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. Any securities issued in the Acquisition are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the Securities Act. The Acquisition will be made solely by means of the scheme document to be published by Tyman in due course, or (if applicable) pursuant to an offer document to be published by Quanex, which (as applicable) would contain the full terms and conditions of the Acquisition. Any decision in respect of, or other response to, the Acquisition, should be made only on the basis of the information contained in such document(s) and the Proxy Statement. If, in the future, Quanex ultimately seeks to implement the Acquisition by way of a takeover offer or otherwise in a manner that is not exempt from the registration requirements of the Securities Act, that offer will be made in compliance with applicable US laws and regulations.

This press release does not constitute a prospectus or a prospectus exempted document.

Participants in the Solicitation

Quanex and certain of its directors and executive officers and employees may be considered participants in the solicitation of proxies from the stockholders of Quanex in respect of the Acquisition, including the share issuance proposal. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the stockholders of Quanex in connection with the Acquisition, including a description of their direct or indirect interests, by security holdings or otherwise, are set forth in the Proxy Statement. Additional information regarding Quanex’s directors and executive officers is contained in Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023 and its annual meeting proxy statement on Schedule 14A, dated January 25, 2024, which are filed with the SEC.

UK Takeover Code: Profit Forecast

UK Takeover Code

The Acquisition referred to in the paragraph entitled “Recent Events” above is governed by the UK's City Code on Takeovers and Mergers (the “UK Takeover Code”). In accordance with the rules of the UK Takeover Code, Quanex is required to publish certain confirmations in connection with the information set out in this release. These confirmations are set out below.

Quanex Profit Forecast

The following statement in this press release (the “Quanex Profit Forecast”) constitutes an ordinary course profit forecast for the purposes of Rule 28.1(a) and Note 2(b) on Rule 28.1 of the UK Takeover Code:    

“As expected, we are starting to see a seasonal uptick in the demand for our products in North America. Market dynamics in Europe continue to be challenging and volumes are soft; however, we are performing well, and our business is resilient. Based on results to date, conversations with our customers, recent demand trends, and the latest macro data, we are reaffirming our prior guidance for fiscal 2024. On a consolidated basis, we continue to estimate net sales of approximately $1.1 billion, which should result in approximately $145 million to $150 million of Adjusted EBITDA* in fiscal 2024.

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.”

References to “GAAP” in the Quanex Profit Forecast are to U.S. GAAP, being the accounting policies applied in the preparation of the Quanex group’s annual results for the fiscal year ended October 31, 2023.

Basis of preparation

The Quanex Profit Forecast has been prepared on a basis consistent with Quanex’s accounting policies, as set out in the paragraph entitled “Non-GAAP Terminology Definitions and Disclaimers”.

The Quanex Profit Forecast excludes any transaction costs applicable to the Acquisition or any other associated accounting impacts as a direct result of the Acquisition.

Assumptions

The Quanex Profit Forecast is based on the assumptions listed below, any of which could turn out to be incorrect and therefore affect the validity of the Quanex Profit Forecast.

Other important factors and information are contained in Quanex’s most recent Annual Report on Form 10-K, including the risks summarised in the section entitled “Risk Factors”, Quanex’s most recent Quarterly Report on Form 10-Q, and Quanex’s other periodic filings with the SEC and available at https://investors.quanex.com/.

Quanex Directors’ confirmation

With the consent of Tyman, the UK's Panel on Takeovers and Mergers has granted a dispensation from the UK Takeover Code requirement for Quanex’s reporting accountants and financial advisers to prepare reports in respect of the Quanex Profit Forecast.

The Quanex Directors have considered the Quanex Profit Forecast and confirm that it has been properly compiled on the basis of the assumptions set out in this release and that the basis of the accounting used is consistent with Quanex’s accounting policies.

No Profit Forecasts or Estimates

The Quanex Profit Forecast is a profit forecast for the purposes of Rule 28 of the UK Takeover Code.

Other than in respect of the Quanex Profit Forecast, no statement in this release is intended as, or is to be construed as, a profit forecast or profit estimate for any period and no statement in this release should be interpreted to mean that earnings or earnings per unit of common stock for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per unit of common stock.

For the purposes of Rule 28 of the UK Takeover Code, the Quanex Profit Forecast contained in this release is the responsibility of Quanex and the Quanex Directors.

Publication on Website

A copy of this release will be made available on Quanex’s website at https://www.roadto2b.com/ by no later than 12 noon (London time) on the business day following the date of this release. Neither the contents of that website nor the content of any other website accessible from hyperlinks on such website is incorporated into, or forms part of, this release.

 
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME
(In thousands, except per share data)
(Unaudited)
         
         
  Three Months Ended April 30, Six Months Ended April 30,
  2024 2023 2024 2023
         
Net sales $266,201  $273,535  $505,356  $535,451 
Cost of sales  199,963   206,372   387,686   416,521 
Selling, general and administrative  34,707   27,371   67,070   64,115 
Depreciation and amortization  10,894   10,456   22,046   21,076 
Operating income  20,637   29,336   28,554   33,739 
Interest expense  (950)  (2,244)  (2,018)  (4,503)
Other, net  4   (29)  1,046   189 
Income before income taxes  19,691   27,063   27,582   29,425 
Income tax expense  (4,314)  (5,551)  (5,956)  (6,004)
Net income $15,377  $21,512  $21,626  $23,421 
         
Earnings per common share, basic $0.47  $0.65  $0.66  $0.71 
Earnings per common share, diluted $0.46  $0.65  $0.65  $0.71 
         
Weighted average common shares outstanding:       
Basic  32,870   32,858   32,847   32,905 
Diluted  33,103   33,017   33,076   33,070 
         
Cash dividends per share $0.08  $0.08  $0.16  $0.16 
         


 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
     
  April 30, 2024 October 31, 2023
ASSETS    
Current assets:    
Cash and cash equivalents $56,149  $58,474 
Accounts receivable, net  87,078   97,311 
Inventories  101,446   97,959 
Income taxes receivable  6,054   8,298 
Prepaid and other current assets  12,776   11,558 
Total current assets  263,503   273,600 
Property, plant and equipment, net  252,857   250,664 
Operating lease right-of-use assets  65,019   46,620 
Goodwill  184,481   182,956 
Intangible assets, net  68,667   74,115 
Other assets  2,686   3,188 
Total assets $837,213  $831,143 
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Accounts payable $60,615  $74,371 
Accrued liabilities  48,851   50,319 
Income taxes payable  -   384 
Current maturities of long-term debt  2,632   2,365 
Current operating lease liabilities  6,433   7,224 
Total current liabilities  118,531   134,663 
Long-term debt  51,549   66,435 
Noncurrent operating lease liabilities  59,965   40,361 
Deferred income taxes  29,280   29,133 
Other liabilities  11,766   14,997 
Total liabilities  271,091   285,589 
Stockholders’ equity:    
Common stock  371   372 
Additional paid-in-capital  249,502   251,576 
Retained earnings  425,650   409,318 
Accumulated other comprehensive loss  (34,631)  (38,141)
Treasury stock at cost  (74,770)  (77,571)
Total stockholders’ equity  566,122   545,554 
Total liabilities and stockholders' equity $837,213  $831,143 
     


 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
    
 Six Months Ended April 30,
 2024 2023
Operating activities:   
Net income$21,626  $23,421 
Adjustments to reconcile net income to cash provided by operating activities:   
Depreciation and amortization 22,046   21,076 
Stock-based compensation 1,365   1,398 
Deferred income tax (155)  97 
Other, net 162   982 
Changes in assets and liabilities:   
Decrease in accounts receivable 10,832   11,564 
(Increase) decrease in inventory (3,008)  14,799 
Increase in other current assets (1,124)  (1,746)
Decrease in accounts payable (12,619)  (19,825)
Decrease in accrued liabilities (4,602)  (14,407)
Increase (decrease) in income taxes payable 1,856   (1,754)
Increase in deferred pension benefits -   17 
Increase in other long-term liabilities 9   1,808 
Other, net 557   1,030 
Cash provided by operating activities 36,945   38,460 
Investing activities:   
Business acquisition -   (91,302)
Capital expenditures (17,183)  (15,074)
Proceeds from disposition of capital assets 93   101 
Cash used for investing activities (17,090)  (106,275)
Financing activities:   
Borrowings under credit facilities -   102,000 
Repayments of credit facility borrowings (15,000)  (35,000)
Repayments of other long-term debt (954)  (1,306)
Common stock dividends paid (5,294)  (5,320)
Issuance of common stock 554   99 
Payroll tax paid to settle shares forfeited upon vesting of stock (1,193)  (567)
Purchase of treasury stock -   (5,593)
Cash (used for) provided by financing activities (21,887)  54,313 
Effect of exchange rate changes on cash and cash equivalents (293)  1,905 
Decrease in cash and cash equivalents (2,325)  (11,597)
Cash and cash equivalents at beginning of period 58,474   55,093 
Cash and cash equivalents at end of period$56,149  $43,496 
    


        
QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
 
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
        
 Three Months Ended April 30, Six Months Ended April 30,
 2024 2023 2024 2023
Cash provided by operating activities$33,091 $35,325 $36,945 $38,460
Capital expenditures(7,603) (7,492) (17,183) (15,074)
Free Cash Flow$25,488 $27,833 $19,762 $23,386
        
        
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
        
 As of April 30,  
 2024 2023    
Revolving credit facility$0 $80,000    
Finance lease obligations(1)55,217 55,626    
Total debt(2)55,217 135,626    
Less: Cash and cash equivalents56,149 43,496    
Net Debt($932) $92,130    
        
(1) Includes $51.0 million and $53.1 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30, 2024 and April 30, 2023, respectively.
(2) Excludes outstanding letters of credit.
        


 
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
           
Reconciliation of Last Twelve Months Adjusted EBITDA Three Months Ended April 30, 2024 Three Months Ended January 31, 2024 Three Months Ended October 31, 2023 Three Months Ended July 31, 2023 Total
  Reconciliation Reconciliation Reconciliation Reconciliation Reconciliation
Net income as reported $15,377  $6,249  $27,382  $31,698  $80,706 
Income tax expense  4,314   1,642   4,442   4,099   14,497 
Other, net  (4)  (1,042)  6,110   (402)  4,662 
Interest expense  950   1,068   1,565   2,068   5,651 
Depreciation and amortization  10,894   11,152   11,194   10,596   43,836 
EBITDA  31,531   19,069   50,693   48,059   149,352 
Cost of sales(1),(2)  631   -   (35)  -   596 
Selling, general and administrative(1),(2),(3)  7,862   205   109   395   8,571 
Adjusted EBITDA $40,024  $19,274  $50,767  $48,454  $158,519 
           
(1) Expense related to plant closure.
(2) Loss on damage to manufacturing facilities caused by weather.
(3) Transaction and advisory fees.
           


 
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
                  
                  
Reconciliation of Adjusted Net Income and Adjusted EPS Three Months Ended
April 30, 2024
 Three Months Ended
April 30, 2023
 Six Months Ended
April 30, 2024
 Six Months Ended
April 30, 2023
 
  Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS 
Net income as reported $15,377  $0.46  $21,512  $0.65  $21,626  $0.65  $23,421  $0.71  
Net income reconciling items from below  6,409  $0.20   195  $0.01   5,974  $0.18   4,349  $0.13  
Adjusted net income and adjusted EPS $21,786  $0.66  $21,707  $0.66  $27,600  $0.83  $27,770  $0.84  
                  
Reconciliation of Adjusted EBITDA Three Months Ended
April 30, 2024
 Three Months Ended
April 30, 2023
 Six Months Ended
April 30, 2024
 Six Months Ended
April 30, 2023
 
  Reconciliation   Reconciliation   Reconciliation   Reconciliation   
Net income as reported $15,377    $21,512    $21,626    $23,421    
Income tax expense  4,314     5,551     5,956     6,004    
Other, net  (4)    29     (1,046)    (189)   
Interest expense  950     2,244     2,018     4,503    
Depreciation and amortization  10,894     10,456     22,046     21,076    
EBITDA  31,531     39,792     50,600     54,815    
EBITDA reconciling items from below  8,493     111     8,698     5,559    
Adjusted EBITDA $40,024    $39,903    $59,298    $60,374    
                  
Reconciling Items Three Months Ended
April 30, 2024
 Three Months Ended
April 30, 2023
 Six Months Ended
April 30, 2024
 Six Months Ended
April 30, 2023
 
  Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items 
Net sales $266,201  $-  $273,535  $-  $505,356  $-  $535,451  $-  
Cost of sales  199,963   (631)(1) 206,372   (48)(2) 387,686   (631)(1) 416,521   (48)(2)
Selling, general and administrative  34,707   (7,862)(1), (3) 27,371   (63)(2), (3) 67,070   (8,067)(1), (3) 64,115   (5,511)(2), (3)
EBITDA  31,531   8,493   39,792   111   50,600   8,698   54,815   5,559  
Depreciation and amortization  10,894   -   10,456   -   22,046   -   21,076   -  
Operating income  20,637   8,493   29,336   111   28,554   8,698   33,739   5,559  
Interest expense  (950)  -   (2,244)  -   (2,018)  -   (4,503)  -  
Other, net  4   (92)(4) (29)  132 (4) 1,046   (847)(4) 189   90 (4)
Income before income taxes  19,691   8,401   27,063   243   27,582   7,851   29,425   5,649  
Income tax expense  (4,314)  (1,992)(5) (5,551)  (48)(5) (5,956)  (1,877)(5) (6,004)  (1,300)(4)
Net income $15,377  $6,409  $21,512  $195  $21,626  $5,974  $23,421  $4,349  
                  
Diluted earnings per share $0.46    $0.65    $0.65    $0.71    
                  
                  
(1) Expense related to plant closure.
(2) Loss on damage to manufacturing facilities caused by weather.
(3) Transaction and advisory fees.
(4) Pension settlement (refund) expense and foreign currency transaction losses (gains).
(5)Tax impact of net income reconciling items.
                  


 
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
           
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
  NA Fenestration EU Fenestration NA Cabinet Components Unallocated
Corp & Other
 Total
Three months ended April 30, 2024          
Net sales $159,774  $56,583  $51,078  $(1,234) $266,201 
Cost of sales  122,261   35,694   42,624   (616)  199,963 
Gross Margin  37,513   20,889   8,454   (618)  66,238 
Gross Margin %  23.5%  36.9%  16.6%    24.9%
Selling, general and administrative(1)  13,730   7,873   5,066   8,038   34,707 
Depreciation and amortization  5,218   2,538   3,082   56   10,894 
Operating income (loss)  18,565   10,478   306   (8,712)  20,637 
Depreciation and amortization  5,218   2,538   3,082   56   10,894 
EBITDA  23,783   13,016   3,388   (8,656)  31,531 
Expense related to plant closure (Cost of sales)    -   631   -   631 
Expense related to plant closure (SG&A)  -   -   978   -   978 
Transaction and advisory fees  -   -   -   6,884   6,884 
Adjusted EBITDA $23,783  $13,016  $4,997  $(1,772) $40,024 
Adjusted EBITDA Margin %  14.9%  23.0%  9.8%    15.0%
           
Three months ended April 30, 2023          
Net sales $156,975  $63,763  $53,518  $(721) $273,535 
Cost of sales  122,472   40,452   43,731   (283)  206,372 
Gross Margin  34,503   23,311   9,787   (438)  67,163 
Gross Margin %  22.0%  36.6%  18.3%    24.6%
Selling, general and administrative(1)  14,158   8,452   5,971   (1,210)  27,371 
Depreciation and amortization  5,050   2,353   2,970   83   10,456 
Operating income  15,295   12,506   846   689   29,336 
Depreciation and amortization  5,050   2,353   2,970   83   10,456 
EBITDA  20,345   14,859   3,816   772   39,792 
Loss on damage to manufacturing facilities (Cost of sales)  35   -   13   -   48 
Loss on damage to manufacturing facilities (SG&A)  -   -   200   -   200 
Transaction and advisory fees  -   -   -   (137)  (137)
Adjusted EBITDA $20,380  $14,859  $4,029  $635  $39,903 
Adjusted EBITDA Margin %  13.0%  23.3%  7.5%    14.6%
           
Six months ended April 30, 2024          
Net sales $307,769  $106,020  $94,215  $(2,648) $505,356 
Cost of sales  240,629   67,397   81,367   (1,707)  387,686 
Gross Margin  67,140   38,623   12,848   (941)  117,670 
Gross Margin %  21.8%  36.4%  13.6%    23.3%
Selling, general and administrative(1)  29,640   15,618   10,192   11,620   67,070 
Depreciation and amortization  10,693   5,096   6,147   110   22,046 
Operating income (loss)  26,807   17,909   (3,491)  (12,671)  28,554 
Depreciation and amortization  10,693   5,096   6,147   110   22,046 
EBITDA  37,500   23,005   2,656   (12,561)  50,600 
Expense related to plant closure (Cost of sales)  -   -   631   -   631 
Expense related to plant closure (SG&A)  -   -   978   -   978 
Transaction and advisory fees  -   -   -   7,089   7,089 
Adjusted EBITDA $37,500  $23,005  $4,265  $(5,472) $59,298 
Adjusted EBITDA Margin %  12.2%  21.7%  4.5%    11.7%
           
Six months ended April 30, 2023          
Net sales $309,955  $118,715  $108,192  $(1,411) $535,451 
Cost of sales  247,189   78,155   91,787   (610)  416,521 
Gross Margin  62,766   40,560   16,405   (801)  118,930 
Gross Margin %  20.3%  34.2%  15.2%    22.2%
Selling, general and administrative(1)  27,453   15,957   10,844   9,861   64,115 
Depreciation and amortization  10,295   4,701   5,904   176   21,076 
Operating income (loss)  25,018   19,902   (343)  (10,838)  33,739 
Depreciation and amortization  10,295   4,701   5,904   176   21,076 
EBITDA  35,313   24,603   5,561   (10,662)  54,815 
Loss on damage to manufacturing facilities (Cost of sales)  35   -   13   -   48 
Loss on damage to manufacturing facilities (SG&A)  -   -   200   -   200 
Transaction and advisory fees  -   -   -   5,311   5,311 
Adjusted EBITDA $35,348  $24,603  $5,774  $(5,351) $60,374 
Adjusted EBITDA Margin %  11.4%  20.7%  5.3%    11.3%
           
(1) Includes stock-based compensation expense for the three and six months ended April 30, 2024, respectively of $1.5 million and $4.1 million and $0.4 million and $5.2 million for the comparable prior year periods.
           


 
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
         
  Three Months Ended April 30, Six Months Ended April 30,
  2024 2023 2024 2023
         
NA Fenestration:       
 United States - fenestration$119,646  $120,756  $231,280  $241,523 
 International - fenestration 7,465   8,350   13,609   13,477 
 United States - non-fenestration 27,532   24,334   53,323   47,400 
 International - non-fenestration 5,131   3,535   9,557   7,555 
  $159,774  $156,975  $307,769  $309,955 
EU Fenestration:(1)       
 International - fenestration$46,968  $47,903  $88,719  $90,257 
 International - non-fenestration 9,615   15,860   17,301   28,458 
  $56,583  $63,763  $106,020  $118,715 
NA Cabinet Components:       
 United States - fenestration$3,737  $4,219  $7,412  $8,127 
 United States - non-fenestration 46,990   48,526   86,169   98,575 
 International - non-fenestration 351   773   634   1,490 
  $51,078  $53,518  $94,215  $108,192 
Unallocated Corporate & Other:       
 Eliminations$(1,234) $(721) $(2,648) $(1,411)
  $(1,234) $(721) $(2,648) $(1,411)
         
Net Sales$266,201  $273,535  $505,356  $535,451 
         
(1) Reflects an increase of $0.6 million and $1.6 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2024, respectively.